BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 16194510)

  • 21. [Use of blood products in patients treated surgically for stage I non-small cell lung cancer].
    Peñalver JC; Padilla J; Jordá C; Escrivá J; Cerón J; Calvo V; García A; Pastor J; Blasco E
    Arch Bronconeumol; 2005 Sep; 41(9):484-8. PubMed ID: 16194510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of 250 ten-year survivors after pneumonectomy for non-small-cell lung cancer.
    Riquet M; Mordant P; Pricopi C; Legras A; Foucault C; Dujon A; Arame A; Le Pimpec-Barthes F
    Eur J Cardiothorac Surg; 2014 May; 45(5):876-81. PubMed ID: 24132299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis.
    Luan H; Ye F; Wu L; Zhou Y; Jiang J
    BMC Surg; 2014 May; 14():34. PubMed ID: 24884867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.